AspirinCyclooxygenase 2Cyclooxygenase InhibitorsCyclooxygenase 1Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 InhibitorsProstaglandin-Endoperoxide SynthasesPlatelet Aggregation InhibitorsIbuprofenIndomethacinDinoprostoneThromboxane B2NaproxenProstaglandinsDiclofenacIsoenzymesSulfonamidesPyrazolesArachidonic AcidNitrobenzenesSalicylatesPlatelet AggregationTiclopidinePiroxicamAcetaminophenBlood PlateletsPlatelet Function TestsLipoxygenase InhibitorsThromboxane A2Gastrointestinal DiseasesSulfonesDose-Response Relationship, DrugSulindacDrug Therapy, CombinationSodium SalicylateThromboxanesEpoprostenolLactonesThiazinesStomach UlcerMembrane ProteinsKetoprofen6-Ketoprostaglandin F1 alphaGastrointestinal HemorrhageArachidonic AcidsGastric MucosaAsthma, Aspirin-InducedLipoxygenaseFlurbiprofenEicosanoidsAnalgesics, Non-NarcoticFibrinolytic AgentsEtodolacThromboxane-A SynthaseRisk FactorsDrug InteractionsTablets, Enteric-CoatedAnticoagulantsMasoprocolDouble-Blind MethodWarfarinHemorrhagePeptic UlcerPlatelet ActivationBleeding TimeLipoxinsMeclofenamic AcidTime FactorsKetorolacProstaglandin AntagonistsProstaglandins EPeptic Ulcer HemorrhageThrombosisHydroxyeicosatetraenoic AcidsTreatment OutcomeNitric OxideDrug HypersensitivityArachidonate 5-LipoxygenaseDinoprostProspective StudiesIntramolecular OxidoreductasesOsteoarthritisReceptors, Prostaglandin EAnticarcinogenic AgentsChemopreventionProstaglandins GSalicylic AcidSeminal VesiclesMyocardial InfarctionSulfinpyrazoneDipyridamoleTolmetinAnti-Inflammatory AgentsDrug Resistance4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amineCells, Cultured5,8,11,14-Eicosatetraynoic AcidColorectal NeoplasmsEndothelium, VascularCardiovascular Diseases